Meta-Analysis
Copyright ©The Author(s) 2023.
World J Diabetes. Mar 15, 2023; 14(3): 313-342
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.313
Table 3 Results of the surface under the cumulative ranking curve (%)

WM
BXXD
BXXD + WM
XSLJZD
XSLJZD + WM
SMD
SMD + WM
ZSXPD
ZSXPD + WM
CSLJD
CSLJD + WM
CQWD
JPXZD
Clinical effects2.0351.3475.4922.3256.7742.168.161.9265.1264.5621.5357.3561.36
Nausea and vomiting scores15.7266.5144.9330.5575.5224.7193.7----56.3542.02
Anorexia scores16.26-73.5529.3777.3421.1788.74----43.56-
Early satiety scores10.246.1289.88-48.4116.7383.62----72.6732.36
Bloating scores9.8871.1378.5628.7638.1317.1498.98----67.340.12
MOT9.7224.3652.91-30.2161.4271.20.33-97.2692.2737.0573.27
SS12.6349.8363.51-37.57-55.697.79---33.06-
GAS2.9949.0670.43-81.19-62.9818.51---28.6786.17
Gastric emptying time11.828.0366.8747.69--27.55-30.2293.8994.0877.6122.26
Emptying rate1.8247.77--72.7358.1898.35---21.14-
Adverse drug events25.410.4827.8541.8590.7434.6435.6592.72-84.3959.2457.04-